Islam Makhachev's Brush with Drug Testing: A Tale of Heart Surgery and UFC Triumph
Islam Makhachev, the welterweight champion, is set to defend his title at UFC 330, aiming for a record-breaking 17th consecutive victory. But this isn't his first brush with controversy. A decade ago, Makhachev faced a failed drug test, which, surprisingly, didn't lead to his suspension. This incident, however, was rooted in a heart surgery he underwent in 2014.
In 2015, Makhachev was knocked out by Adriano Martins, a setback that remains his only loss in professional MMA. The following year, he was set to face Drew Dober, but an out-of-competition drug test just before the bout led to his withdrawal. The test revealed the presence of meldonium, a banned substance. However, Makhachev was not suspended, and USADA cleared him of wrongdoing.
The positive test was attributed to a cardiac ablation procedure Makhachev had undergone in December 2014 to treat ventricular arrhythmia. A physician had prescribed meldonium as a preventive measure, which he stopped taking by January 1, 2016, when it became a prohibited substance. Makhachev's transparency about his medical history and his proactive approach to his health are commendable.
In a 2020 interview, Makhachev reflected on the surgery, explaining how it resolved his arrhythmia issues. He emphasized the importance of the procedure for his long-term career prospects, suggesting that refusing it could have led to more severe health complications. Makhachev's willingness to undergo a potentially career-altering surgery demonstrates his dedication to his craft and his commitment to maintaining a healthy lifestyle.
This incident highlights the delicate balance between athletic performance and health. Makhachev's story serves as a reminder that athletes must prioritize their well-being, even if it means making tough decisions that could impact their careers. As he prepares for his upcoming fight, Makhachev's past challenges only add to his allure as a resilient and determined champion.
